These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37423123)
21. Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics. Vuckovic Z; Wang J; Pham V; Mobbs JI; Belousoff MJ; Bhattarai A; Burger WAC; Thompson G; Yeasmin M; Nawaratne V; Leach K; van der Westhuizen ET; Khajehali E; Liang YL; Glukhova A; Wootten D; Lindsley CW; Tobin A; Sexton P; Danev R; Valant C; Miao Y; Christopoulos A; Thal DM Elife; 2023 May; 12():. PubMed ID: 37248726 [TBL] [Abstract][Full Text] [Related]
22. Discovery and Development of Muscarinic Acetylcholine M Takai K; Enomoto T Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510 [TBL] [Abstract][Full Text] [Related]
23. 6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M Jörg M; van der Westhuizen ET; Khajehali E; Burger WAC; White JM; Choy KHC; Tobin AB; Sexton PM; Valant C; Capuano B; Christopoulos A; Scammells PJ ACS Chem Neurosci; 2019 Mar; 10(3):1099-1114. PubMed ID: 30547573 [TBL] [Abstract][Full Text] [Related]
24. Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor. Abdul-Ridha A; Lane JR; Mistry SN; López L; Sexton PM; Scammells PJ; Christopoulos A; Canals M J Biol Chem; 2014 Nov; 289(48):33701-11. PubMed ID: 25326383 [TBL] [Abstract][Full Text] [Related]
25. Discovery of [ Tong L; Li W; Lo MM; Gao X; Wai JM; Rudd M; Tellers D; Joshi A; Zeng Z; Miller P; Salinas C; Riffel K; Haley H; Purcell M; Holahan M; Gantert L; Schubert JW; Jones K; Mulhearn J; Egbertson M; Meng Z; Hanney B; Gomez R; Harrison ST; McQuade P; Bueters T; Uslaner J; Morrow J; Thomson F; Kong J; Liao J; Selyutin O; Bao J; Hastings NB; Agrawal S; Magliaro BC; Monsma FJ; Smith MD; Risso S; Hesk D; Hostetler E; Mazzola R J Med Chem; 2020 Mar; 63(5):2411-2425. PubMed ID: 32101422 [TBL] [Abstract][Full Text] [Related]
26. Development of allosteric modulators of GPCRs for treatment of CNS disorders. Nickols HH; Conn PJ Neurobiol Dis; 2014 Jan; 61():55-71. PubMed ID: 24076101 [TBL] [Abstract][Full Text] [Related]
28. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites. Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966 [TBL] [Abstract][Full Text] [Related]
29. Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors. Lazareno S; Birdsall B; Fukazawa T; Gharagozloo P; Hashimoto T; Kuwano H; Popham A; Sugimoto M; Birdsall NJ Life Sci; 1999; 64(6-7):519-26. PubMed ID: 10069518 [TBL] [Abstract][Full Text] [Related]
30. Restoring Agonist Function at a Chemogenetically Modified M Khajehali E; Bradley S; van der Westhuizen ET; Molloy C; Valant C; Finlayson L; Lindsley CW; Sexton PM; Tobin AB; Christopoulos A ACS Chem Neurosci; 2020 Dec; 11(24):4270-4279. PubMed ID: 33196174 [TBL] [Abstract][Full Text] [Related]
32. Role of Conserved Tyrosine Lid Residues in the Activation of the M Pham V; Habben Jansen MCC; Thompson G; Heitman LH; Christopoulos A; Thal DM; Valant C Mol Pharmacol; 2023 Sep; 104(3):92-104. PubMed ID: 37348914 [TBL] [Abstract][Full Text] [Related]
33. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders. Digby GJ; Shirey JK; Conn PJ Mol Biosyst; 2010 Aug; 6(8):1345-54. PubMed ID: 20582339 [TBL] [Abstract][Full Text] [Related]
34. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators. Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343 [TBL] [Abstract][Full Text] [Related]
35. Identification of a Novel Allosteric Site at the M Burger WAC; Gentry PR; Berizzi AE; Vuckovic Z; van der Westhuizen ET; Thompson G; Yeasmin M; Lindsley CW; Sexton PM; Langmead CJ; Tobin AB; Christopoulos A; Valant C; Thal DM ACS Chem Neurosci; 2021 Aug; 12(16):3112-3123. PubMed ID: 34351123 [TBL] [Abstract][Full Text] [Related]
36. 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor. Mistry SN; Jörg M; Lim H; Vinh NB; Sexton PM; Capuano B; Christopoulos A; Lane JR; Scammells PJ J Med Chem; 2016 Jan; 59(1):388-409. PubMed ID: 26624844 [TBL] [Abstract][Full Text] [Related]
38. Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M Butler CR; Popiolek M; McAllister LA; LaChapelle EA; Kramer M; Beck EM; Mente S; Brodney MA; Brown M; Gilbert A; Helal C; Ogilvie K; Starr J; Uccello D; Grimwood S; Edgerton J; Garst-Orozco J; Kozak R; Lotarski S; Rossi A; Smith D; O'Connor R; Lazzaro J; Steppan C; Steyn SJ J Med Chem; 2024 Jul; 67(13):10831-10847. PubMed ID: 38888621 [TBL] [Abstract][Full Text] [Related]
39. Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors. Jakubík J; Randáková A; El-Fakahany EE; Dolezal V BMC Pharmacol; 2009 Dec; 9():15. PubMed ID: 20038295 [TBL] [Abstract][Full Text] [Related]
40. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects. Valant C; Felder CC; Sexton PM; Christopoulos A Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]